CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Shares withheld for taxes President and CEO gave up 18,157 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 2,485 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 16,011 shares at an average $6.90 ($110,547)
- 4 Grant or award Acting Chief Financial Officer acquired 1,259 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 650 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 917 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 1,486 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Scientific Officer gave up 4,131 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 4,133 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 15,689 shares (to pay taxes)
Page 5 of 34 · 674 filings